Spontaneous perforation of the cystic duct in streptococcal toxic shock syndrome: a case report by Endeman, Henrik et al.
BioMed  Central
Page 1 of 4
(page number not for citation purposes)
Journal of Medical Case Reports
Open Access Case report
Spontaneous perforation of the cystic duct in streptococcal toxic 
shock syndrome: a case report
Henrik Endeman*1, David A Ligtenstein2 and Heleen M Oudemans-van 
Straaten1
Address: 1Onze Lieve Vrouwe Gasthuis, Department of Intensive Care Medicine, Oosterpark 9, PB 95500, 1090 HM Amsterdam, the Netherlands 
and 2Ruwaard van Putten Ziekenhuis, Department of Surgery, PB 777, 3200 GA Spijkenisse, the Netherlands
Email: Henrik Endeman* - henrik.endeman@planet.nl; David A Ligtenstein - ligtenstein@xs4all.nl; Heleen M Oudemans-van 
Straaten - h.m.oudemans-vanstraaten@olvg.nl
* Corresponding author    
Abstract
Introduction: Streptococcal toxic shock syndrome is a complication of group A streptococcal
infection, most often originating from the skin. The syndrome is characterized by fever,
hypotension and multiple organ failure. Mortality rate may be as high as 80%.
Case presentation: A 25-year-old man of Indian origin presented with abdominal complaints,
rash and fever after an episode of pharyngitis. The patient was operated and a biliary peritonitis was
found caused by perforation of the cystic duct in the absence of calculi. Cholecystectomy was
performed, but after the operation, the patient's condition worsened and multi-organ failure
developed. Group A streptococci were cultured in blood taken at admission and streptococcal
toxic shock syndrome was diagnosed. Treatment consisted of antibiotics, corticosteroids,
immunoglobulin and supportive treatment for haemodynamic, respiratory and renal failure.
Conclusion:  This is a patient with streptococcal toxic shock syndrome complicated by
spontaneous perforation of the cystic duct. Spontaneous perforation of the cystic duct is a rare
finding, most often reported in children and secondary to anatomic defects. We found only one
similar adult case in the literature. Perforation may be due to microthrombosis and ischaemia, and
so be a part of the multi-organ failure often found in streptococcal toxic shock syndrome.
Introduction
Streptococcal toxic shock syndrome (StrepTSS) is caused
by beta-haemolytic streptococcus group A (M-1 strain)
most frequently originating from an infection of the skin
(cellulitis or erysipelas), pharynx or vagina [1,2]. StrepTSS
is defined as 1) isolation of streptococcus group A, 2)
hypotension and two of the following signs: renal impair-
ment (acute renal failure, ARF), coagulopathy (diffuse
intravascular coagulation, DIC), liver involvement, adult
respiratory distress syndrome (ARDS), erythematous mac-
ular rash or soft tissue necrosis [1]. StrepTSS is reported in
three age groups: children (0 to 15 years), young adults
(24 to 44) and elderly (65+). StrepTSS in adults is associ-
ated with alcohol abuse, corticosteroid use, diabetes mel-
litus, heart and lung diseases, HIV/AIDS, malignancy,
peripheral vascular disease, recent varicella/influenza
infection and living in a nursing home [1,2]. Mortality of
StrepTSS is 33% up to 81% [1]. Other infections associ-
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ated with StrepTSS are cerebral empyema, endocarditis,
endophthalmitis, lymphangitis, mediastinitis, meningitis,
myositis, necrotizing fasciitis, osteomyelitis, pelvic infec-
tion, peritonitis, puerperal and postpartum infections,
septic arthritis, thrombophlebitis (intravenous drug
abuse), upper and lower respiratory tract infections
(including otitis media) and urinary tract infection [1].
The classic clinical picture of StrepTSS is an acute febrile
illness, beginning with mild viral symptoms and involves
a minor soft tissue infection or upper airway infection that
progresses to shock, multi-organ failure (MOF) and death
[1,2]. An initial viral infection causes damage to the
mucosa, thus facilitating penetration of group A strepto-
coccus.
In this case report, we present a patient with StrepTSS with
a rare complication: spontaneous perforation of the cystic
duct.
Case presentation
A 25-year-old formerly healthy Hindu man, living in the
Netherlands from birth, was admitted to our Intensive
Care Unit (ICU) after abdominal surgery in a hospital out-
side our region. The patient presented in that hospital one
day before operation with fever and moderate abdominal
complaints. One week before, he became ill with fever,
sore throat and red-yellow macular discoloration on his
extremities and thorax. The week before, his girlfriend, an
employee of a kindergarten, had similar symptoms, but
she recovered. After a few days, his fever and sore throat
disappeared, but then he developed a second phase of
fever, accompanied by nausea, vomitus (once), dark col-
oured urine and a single passage of watery, possibly dis-
coloured, stool.
At presentation in the hospital, the patient had fever
(40°C) and tachycardia (150/minute). On clinical exam-
ination, the patient had diffuse abdominal tenderness.
Skin lesions had resolved. Laboratory examination
revealed signs of inflammation (C-reactive protein (C-
RP), 294 mg/litre; white blood cells (WBC), 3.8 × 109/
litre; 50% rods) and cholestasis (total bilirubin, 100
μmol/litre; conjugate bilirubin, 63 μmol/litre; alkaline
phosphatase (AF), 168 U/litre and gamma glutamyl trans-
ferase (γGT), 241 U/litre). Ultrasound and computed
tomography (CT) scan of his abdomen showed no abnor-
malities, especially no signs of cholecystitis or cholangitis
(including the absence of cholecysto- and choledocho-
lithiasis). Laparotomy was performed because of progres-
sive abdominal complaints in combination with shock,
and revealed a biliary peritonitis due to a pinpoint perfo-
ration of the base of the cystic duct. Gallbladder and com-
mon bile duct were free of stones, but the cystic duct
looked inflamed and necrotic. Peritoneal lavage and
cholecystectomy were performed. Postoperative course
was complicated by severe septic shock with MOF includ-
ing ARDS, ARF and DIC. In cultures of blood taken on
admission, a beta-haemolytic streptococcus group A was
isolated.
The patient was transported to our ICU with refractory
hypotension despite high-dosage noradrenalin, pulmo-
nary insufficiency requiring high-pressure ventilation
(positive end expiratory pressure (PEEP), 20 mmH2O;
FiO2 70%) and oliguria. Clinical and laboratory parame-
ters at admission to our ICU are shown in Table 1. Chest
X-ray showed bilateral patchy infiltrates without cardiac
enlargement. The patient was diagnosed as suffering from
StrepTSS with MOF complicated by spontaneous perfora-
tion of the cystic duct and biliary peritonitis.
Treatment consisted of our standard pre-emptive antibiot-
ics for abdominal sepsis (cefotaxime 1 g four times daily,
initially combined with ciprofloxacin and metronidazol)
in combination with corticosteroids and immunoglobu-
lin (30 g intravenous immunoglobulin daily for 5 consec-
utive days). After blood cultures were positive for
streptococcus group A, ciprofloxacin and metronidazol
were stopped. Supportive therapy consisted of mechanical
ventilation (initially in the prone position), fluid resusci-
tation in combination with inodilators (enoximone),
vasodilators (nitroglycerin) and vasoconstrictors (high-
dose dopamine and a short period of noradrenalin), sele-
Table 1: Laboratory results at admission after transfer to ICU
Parameter Results
Haemoglobin 6.4 mmol/litre
White blood cell count (WBC) 10.6 × 103/litre (59% rods)
Platelets 68 × 103/litre
C-reactive protein 149 mg/litre
PTT 16.8 seconds
APTT 41.6 seconds
Antithrombin III 35 g/litre
Fibrinogen 2 g/litre
d-dimer 45,700 mcg/litre
pH 7.22
pCO2 50 mmHg
pO2 74 mmHg
Bicarbonate 20.2 mmol/litre
Sodium 140 mmol/litre
Potassium 4 mmol/litre
Chloride 107 mmol/litre
Urea 12.9 mmol/litre
Creatinine 258 μmol/litre
Albumin 20 g/litre
Total/conjugated bilirubin 74/67 μmol/litre
Alkaline phosphatase 97 U/litre
γGT 91 U/litre
ALAT 152 U/litre
ASAT 317 U/litre
Creatine kinase 2563 mmol/litreJournal of Medical Case Reports 2008, 2:338 http://www.jmedicalcasereports.com/content/2/1/338
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nium and selective decontamination of the digestive tract.
Cefotaxime was continued because the patient's condi-
tion and inflammatory markers improved. On day 5, he
was successfully weaned from mechanical ventilation. At
this time, his platelet count had recovered and renal func-
tion was improving. Renal replacement therapy was not
necessary. After 7 days of treatment in our ICU, he
returned to a hospital in his home region. His close rela-
tives were advised to take a prophylactic macrolide for 5
days. Pathologic examination of the gallbladder showed
acute inflammation without bacteria and without stones.
Discussion
This patient was diagnosed as suffering from StrepTSS
originating from an upper respiratory infection, either
viral or streptococcal pharyngitis, and fulfilled the diag-
nostic criteria for StrepTSS (isolation of streptococcus
group A, hypotension, ARDS, renal insufficiency, DIC).
The streptococcus group A likely originated from his girl-
friend who worked in a kindergarten. Apart from a possi-
ble viral infection, our patient had no evident risk factors.
His clinical features were classical: acute febrile illness,
beginning with mild viral symptoms originating from the
upper airways with progression to MOF.
Spontaneous perforation of the cystic and/or common
bile duct as a complication of StrepTSS has not been
reported before in adults. Perforation of the intra- or ext-
rahepatic biliary tract is rare. In adults, most cases of non-
traumatic perforation of the biliary tract are due to
obstruction by stones (or tumours) resulting in increased
ductal pressure, cholangitis and eventually necrosis and
perforation [3,4]. There are a few reports of adult patients
with spontaneous perforation in the absence of calculi
and only one of perforation of the cystic duct as in our
patient. In this patient, perforation of the cystic duct was
due to acalculous cholecystitis [5]. Clinical features of
nontraumatic perforation of the bile ducts in adults are
acute abdominal pain and febrile illness, sometimes in
combination with elevated bilirubin, especially in the case
of stones [4]. All three features were present in our patient,
though he did not suffer from biliary stone disease. The
elevated bilirubin in our patient was due to hepatic insuf-
ficiency as part of the multi-organ dysfunction syndrome.
CT scan or ultrasonography may show non-specific find-
ings such as (perihepatic) fluid and, in the case of stones,
obstructive lesions in the biliary tract [4]. The combina-
tion of biliary stone disease, acute abdominal complaints
and increased inflammatory parameters is an indication
for the presence of nontraumatic perforation of the biliary
tract, especially in combination with perihepatic fluid on
radiological examination of the abdomen. In the absence
of stones, definitive diagnosis can only be made by
laparotomy.
Spontaneous perforation of the biliary tract in the absence
of gallstones is mostly reported in (young) children.
Mechanisms of perforation of the biliary tract are biliary
tract anomalies (especially cysts), ascariasis and cholecys-
titis [6-8]. A possible mechanism of spontaneous perfora-
tion of the cystic duct in our patient is local necrosis due
to microcirculatory failure as a result of hypoperfusion
and microthrombosis. This resembles the case reported by
Shah and Webber where spontaneous perforation of the
common bile duct was due to acalculous cholecystitis,
which is probably also caused by diminished local micro-
circulation [5]. Most cases of spontaneous perforation of
the biliary tract in childhood are reported in children of
African or Asian ethnicity; our patient was of Indian ori-
gin. The pathophysiological role of ethnicity is unknown.
Treatment of spontaneous perforation of the biliary tract
consists of cholecystectomy and, in the case of obstruc-
tion, external or internal drainage of the biliary tract.
Management of StrepTSS consists of treatment of the loca-
tion of infection (for example, debridement of infected
soft tissue), antibiotics and support of failing organ func-
tions. Definitive studies establishing the most effective
antibiotic for StrepTSS are not available. Penicillin and
clindamycin are the classical choice [1,2]. We applied
selective decontamination of the digestive tract to prevent
secondary infectious complications, especially ventilator
associated pneumonia [9,10]. The systemic part of this
strategy consisted of cefotaxime, which also has strepto-
coccal coverage. We preferred treatment with cefotaxime
over penicillin and clindamycin, because the latter two
also eradicate non-pathogenic endogenous anaerobic bac-
teria, thereby facilitating acquisition of non-endogenous
Gram-negative bacteria or Clostridium difficile [11]. Cipro-
floxacin and metronidazole, initiated for abdominal sep-
sis with unknown cause, were discontinued as soon as
cultures were present. Ciprofloxacin has no direct killing
effects on anaerobes and metronidazole is rapidly inacti-
vated in faeces.
Our haemodynamic support not only focused on restora-
tion of pressure, but additionally of flow in the systemic
microcirculation using fluids, inodilatation and vasodila-
tion with enoximone and nitroglycerin [12,13]. The
patient would have been eligible for treatment with acti-
vated protein C, but his recent operation was a contrain-
dication for activated protein C. Further treatment
consisted of corticosteroids [14], selenium [15] and
immunoglobulin. Immune-modulation using intrave-
nous immunoglobulin is recognized as a therapy with
potential benefits in StrepTSS. Possible effects of intrave-
nous immunoglobulin consist of enhancing phagocyto-
sis, neutralization of toxic mediated effects and induction
of regulatory cytokines resulting in suppression of the
pro-inflammatory response [16]. This combined anti-Publish with BioMed Central    and   every 
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inflammatory strategy may be crucial to enhance recovery
if hospital acquired infectious complications are under
control with selective decontamination of the digestive
tract.
Conclusion
StrepTSS is a severe infectious disease characterized by
high mortality and MOF. Perforation of the cystic duct is
a rare complication of StrepTSS. Perforation of the cystic
duct is possibly caused by alteration in the local microcir-
culation leading to necrosis and eventually perforation.
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